{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:19:19Z","timestamp":1757618359321,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303059"],"award-info":[{"award-number":["82303059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2022A1515111090"],"award-info":[{"award-number":["2022A1515111090"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2023113"],"award-info":[{"award-number":["A2023113"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02857-4","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:09:03Z","timestamp":1750925343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TET3 facilitates bladder cancer progression through targeted modulation of stemness pathways"],"prefix":"10.1007","volume":"42","author":[{"given":"Zhiren","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2857_CR1","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1038\/s41467-023-39512-3","volume":"14","author":"I Ansari","year":"2023","unstructured":"Ansari I, Sole-Boldo L, Ridnik M, Gutekunst J, Gilliam O, Korshko M, Liwinski T, Jickeli B, Weinberg-Corem N, Shoshkes-Carmel M, et al. TET2 and TET3 loss disrupts small intestine differentiation and homeostasis. Nat Commun. 2023;14:4005.","journal-title":"Nat Commun"},{"key":"2857_CR2","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat Rev. 2023;115:102530.","journal-title":"Cancer Treat Rev"},{"key":"2857_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.annonc.2023.09.3116","volume":"35","author":"JWF Catto","year":"2023","unstructured":"Catto JWF, Tran B, Roupret M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, et al. Erdafitinib in BCG-treated high-risk non-muscle invasive bladder cancer. Ann Oncol. 2023;35:98\u2013106.","journal-title":"Ann Oncol"},{"key":"2857_CR4","doi-asserted-by":"publisher","first-page":"2658727","DOI":"10.1155\/2022\/2658727","volume":"2022","author":"J Chi","year":"2022","unstructured":"Chi J, Zhang W, Li Y, Zhao J, Zheng X, Gao M. TET3 mediates 5hmC level and promotes tumorigenesis by activating AMPK pathway in papillary thyroid cancer. Int J Endocrinol. 2022;2022:2658727.","journal-title":"Int J Endocrinol"},{"key":"2857_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/14728222.2017.1297798","volume":"21","author":"C Ciccarese","year":"2017","unstructured":"Ciccarese C, Massari F, Blanca A, Tortora G, Montironi R, Cheng L, Scarpelli M, Raspollini MR, Vau N, Fonseca J, et al. Tp53 and its potential therapeutic role as a target in bladder cancer. Expert Opin Ther Targets. 2017;21:401\u201314.","journal-title":"Expert Opin Ther Targets"},{"key":"2857_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69:300\u201310.","journal-title":"Eur Urol"},{"key":"2857_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2857_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2857_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00018-022-04396-x","volume":"79","author":"K Joshi","year":"2022","unstructured":"Joshi K, Liu S, Breslin SJP, Zhang J. Mechanisms that regulate the activities of TET proteins. Cell Mol Life Sci. 2022;79:363.","journal-title":"Cell Mol Life Sci"},{"key":"2857_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comperat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84:176\u201390.","journal-title":"Eur Urol"},{"key":"2857_CR11","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324:1980\u201391.","journal-title":"JAMA"},{"key":"2857_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.21037\/atm-22-5294","volume":"10","author":"D Li","year":"2022","unstructured":"Li D, Wu X, Fan X, Cheng C, Li D, Zhang W. Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer. Ann Transl Med. 2022;10:1232.","journal-title":"Ann Transl Med"},{"key":"2857_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ijnp\/pyx099","volume":"21","author":"C Liu","year":"2018","unstructured":"Liu C, Sun X, Wang Z, Le Q, Liu P, Jiang C, Wang F, Ma L. Retrieval-induced upregulation of Tet3 in pyramidal neurons of the dorsal hippocampus mediates cocaine-associated memory reconsolidation. Int J Neuropsychopharmacol. 2018;21:255\u201366.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2857_CR14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2023.05.037","volume":"117","author":"F Liu","year":"2023","unstructured":"Liu F, Ma Y, Sun H, Cai H, Liang X, Xu C, Du L, Wang Y, Liu Q. SUMO1 modification stabilizes TET3 protein and increases colorectal cancer radiation therapy sensitivity. Int J Radiat Oncol Biol Phys. 2023;117:942\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2857_CR15","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.labinv.2023.100264","volume":"103","author":"J Liu","year":"2023","unstructured":"Liu J, Sun T, Yin L. ZMIZ1 upregulation of TET3-mediated hydroxymethylation induces M2 polarization of Kupffer cells in hepatocellular carcinogenesis by mediating Notch1\/c-Myc signaling. Lab Investig. 2023;103:100264.","journal-title":"Lab Investig"},{"key":"2857_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2217\/epi-2023-0146","volume":"15","author":"R Liu","year":"2023","unstructured":"Liu R, Feng L, Tang S, Liu Y, Yang Q. The impact and mechanism of TET3 overexpression on the progression of hepatic fibrosis. Epigenomics. 2023;15:577\u201391.","journal-title":"Epigenomics"},{"key":"2857_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s42255-022-00597-7","volume":"4","author":"J Park","year":"2022","unstructured":"Park J, Lee DH, Ham S, Oh J, Noh JR, Lee YK, Park YJ, Lee G, Han SM, Han JS, et al. Targeted erasure of DNA methylation by TET3 drives adipogenic reprogramming and differentiation. Nat Metab. 2022;4:918\u201331.","journal-title":"Nat Metab"},{"key":"2857_CR18","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"2857_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41375-021-01390-3","volume":"36","author":"AJ Pulikkottil","year":"2022","unstructured":"Pulikkottil AJ, Bamezai S, Ammer T, Mohr F, Feder K, Vegi NM, Mandal T, Kohlhofer U, Quintanilla-Martinez L, Sinha A, et al. TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways. Leukemia. 2022;36:416\u201325.","journal-title":"Leukemia"},{"key":"2857_CR20","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1038\/s41467-018-07801-x","volume":"9","author":"D Selimoglu-Buet","year":"2018","unstructured":"Selimoglu-Buet D, Riviere J, Ghamlouch H, Bencheikh L, Lacout C, Morabito M, Diop M, Meurice G, Breckler M, Chauveau A, et al. A miR-150\/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset. Nat Commun. 2018;9:5455.","journal-title":"Nat Commun"},{"key":"2857_CR21","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2857_CR22","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2857_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.gene.2016.07.025","volume":"591","author":"C Yang","year":"2016","unstructured":"Yang C, Li Z, Kang W, Tian Y, Yan Y, Chen W. TET1 and TET3 are essential in induction of Th2-type immunity partly through regulation of IL-4\/13A expression in zebrafish model. Gene. 2016;591:201\u20138.","journal-title":"Gene"},{"key":"2857_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12935-023-03021-6","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Zhao R, Qiao P, Cui J, Chen X, Fan J, Hu A, Huang S. The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1alpha\/VEGF signaling pathway. Cancer Cell Int. 2023;23:206.","journal-title":"Cancer Cell Int"},{"key":"2857_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2022.100701","volume":"22","author":"Z Ye","year":"2022","unstructured":"Ye Z, Jiang Y, Wu J. DNMT3B attenuated the inhibition of TET3 on epithelial-mesenchymal transition in TGF-beta1-induced ovarian cancer by methylating the TET3 promoter. Reprod Biol. 2022;22: 100701.","journal-title":"Reprod Biol"},{"key":"2857_CR26","doi-asserted-by":"publisher","first-page":"914577","DOI":"10.3389\/fimmu.2022.914577","volume":"13","author":"G Yu","year":"2022","unstructured":"Yu G, Bao J, Zhan M, Wang J, Li X, Gu X, Song S, Yang Q, Liu Y, Wang Z, et al. Comprehensive analysis of m5c methylation regulatory genes and tumor microenvironment in prostate cancer. Front Immunol. 2022;13:914577.","journal-title":"Front Immunol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02857-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02857-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02857-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:48:39Z","timestamp":1757198919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02857-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02857-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"284"}}